Natural Products with Halogen-Bearing Stereogenic Centers ...
Natural Products with Halogen-Bearing Stereogenic Centers ...
Natural Products with Halogen-Bearing Stereogenic Centers ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MeO<br />
H<br />
N<br />
<strong>Natural</strong> <strong>Products</strong> <strong>with</strong> <strong>Halogen</strong>-<strong>Bearing</strong> <strong>Stereogenic</strong> <strong>Centers</strong>:<br />
<strong>Natural</strong> Origin and Synthesis<br />
Dr. Jared T. Shaw<br />
Evans Group Seminar<br />
February 1, 2002<br />
Occurrence of <strong>Halogen</strong>ated <strong>Natural</strong> <strong>Products</strong>:<br />
Gribble, G. W., Progress in the Chemistry of Organic <strong>Natural</strong> <strong>Products</strong>, 1996, 68, 1-498. 2288 references!<br />
Gribble, G. W., Acc. Chem. Res., 1998, 31, 141-152.<br />
Constituents of Laurencia:<br />
Erickson, K. L., Marine <strong>Natural</strong> <strong>Products</strong>, 1983, 31-256.<br />
Fluorinated <strong>Natural</strong> <strong>Products</strong>:<br />
Harper, D. B., O'Hagan, D. O., <strong>Natural</strong> Product Reports, 1994, 11, 123-133.<br />
Haloperoxidases:<br />
Butler, A., Walker, J. V., Chem. Rev., 1993, 93, 1937-1944.<br />
Butler, A., Coord. Chem. Rev., 1999, 187, 17-35.<br />
Franssen, M. C. R., Catalysis Today, 1995, 22, 441-457.<br />
Synthesis of <strong>Halogen</strong>ated <strong>Natural</strong> <strong>Products</strong>:<br />
Murai, A., Studies in <strong>Natural</strong> <strong>Products</strong> Chemistry, 1997, 19, 411-461.<br />
<strong>Halogen</strong>ated <strong>Natural</strong> <strong>Products</strong> Synthesized in the Evans Group<br />
Completed:<br />
Br<br />
Me<br />
H<br />
OH<br />
H<br />
O<br />
HO<br />
MeO<br />
N<br />
Epibatidine<br />
shaw 01/02 2/4/02 1:54 PM<br />
Cl<br />
HO<br />
O<br />
O<br />
N<br />
H<br />
H<br />
H<br />
H<br />
O<br />
H<br />
H<br />
H<br />
H<br />
O<br />
Me<br />
O<br />
Me<br />
N Me<br />
H O<br />
O<br />
HO<br />
Cl<br />
O<br />
H<br />
O<br />
N H<br />
H<br />
N<br />
N<br />
H<br />
O H<br />
N<br />
H<br />
NH<br />
O<br />
O<br />
O O<br />
HO<br />
Phorboxazole B<br />
HO<br />
OH<br />
OH<br />
O<br />
OH<br />
HO<br />
Teicoplanin<br />
O<br />
O<br />
HO<br />
O<br />
HO<br />
Cl<br />
HO<br />
O<br />
H<br />
N<br />
H<br />
H<br />
NH<br />
HO<br />
NH<br />
O<br />
Cl<br />
O<br />
H<br />
N<br />
OH<br />
OH<br />
NH 2<br />
O<br />
OH<br />
N<br />
H<br />
O<br />
O<br />
H 2N<br />
Cl<br />
H<br />
N<br />
O<br />
Vancomycin<br />
O<br />
O<br />
Me<br />
In Progress:<br />
Me<br />
MeO<br />
Me<br />
Me<br />
O<br />
H OH<br />
O<br />
OH<br />
NH<br />
Me<br />
O<br />
MeO<br />
Me<br />
O O Me<br />
H<br />
O<br />
O<br />
NH<br />
NHMe<br />
Callipeltoside A<br />
H<br />
Cl
Distribution of <strong>Halogen</strong>ated <strong>Natural</strong> <strong>Products</strong><br />
2500<br />
2000<br />
1500<br />
1000<br />
500<br />
0<br />
16/103<br />
F<br />
Cl<br />
812/2051 630/1782<br />
Br<br />
"Chiral" = Contains A <strong>Halogen</strong>-<strong>Bearing</strong> Stereocenter<br />
Outline<br />
8/70<br />
I<br />
Total<br />
"Chiral"<br />
I. Fluorinated natural products<br />
II. Chlorinated/brominated natural products<br />
A. biogenesis<br />
B. Methods of stereoselective chlorination and bromination<br />
1. SN2 Displacement: "X - "<br />
2. Electrophilic halogenation: "X + "<br />
3. Polycyclization<br />
4. Acyclic stereocontrol employing haloalkenes<br />
5. The Kharasch reaction<br />
C. Syntheses<br />
1. Oppositiol, prepinnaterpene, laurencial, dactylyne<br />
2. Comparative syntheses of laurencin and related structures<br />
3. Comparative syntheses of kumausyne and kumausallene<br />
4. Syntheses aplysiapyranoids and thyrsiferol/venusatriol by electrophilic monocyclization<br />
5. Selected polycyclzations leading to natural products<br />
6. Diels-Alder spproaches to plocamium natural products and virantmycin<br />
7. Callipeltoside sidechain<br />
8. Halomon<br />
9. Outlyers: Hapalindole G & Axinellamines<br />
shaw 03/04 2/4/02 1:56 PM
HO<br />
F<br />
O<br />
N<br />
N<br />
O O<br />
Me Me<br />
The Fluorinated <strong>Natural</strong> <strong>Products</strong><br />
•Most fluorinated natural products are derived from fluoroacetyl Co-A<br />
F<br />
H 2NSO 2<br />
F<br />
O<br />
O<br />
SCoA<br />
SCoA<br />
n<br />
n=4, 6, 7, 8<br />
NHBz<br />
shaw 05/06 2/4/02 1:57 PM<br />
N<br />
F<br />
N<br />
MsCl;<br />
KOt-Bu<br />
58%<br />
O<br />
N<br />
N<br />
HO OH<br />
Nucleocidin<br />
OH<br />
OH<br />
F<br />
O<br />
O<br />
OH<br />
Me<br />
HO2C OH<br />
HO2C CO2H F<br />
(2R, 3R)-2-fluorocitric acid<br />
F<br />
H 2NSO 2<br />
The Fluorinated <strong>Natural</strong> <strong>Products</strong>:<br />
Moffatt's Synthesis of Nucleocidin<br />
NH 2<br />
N<br />
N<br />
N<br />
O N<br />
O O<br />
Me Me<br />
N<br />
TFA/<br />
H 2O<br />
77%<br />
NHBz<br />
N<br />
BzCl/Pyr<br />
97%<br />
H 2NSO 2<br />
F<br />
N<br />
O N<br />
O O<br />
Me Me<br />
N<br />
O N<br />
O O<br />
Me Me<br />
NH 2<br />
N<br />
N<br />
N<br />
O<br />
NBz 2<br />
N<br />
F<br />
H<br />
F<br />
O<br />
OH<br />
N<br />
N<br />
HO OH<br />
F<br />
Nucleocidin<br />
AgF/I 2<br />
77%<br />
(Bu 3Sn) 2O;<br />
H 2NSO 2Cl<br />
87%<br />
NH 2<br />
O<br />
NH 2<br />
N<br />
O<br />
OH<br />
N<br />
OH<br />
4-fluorothreonine<br />
I<br />
F<br />
Gribble, 1996<br />
N<br />
O N<br />
NBz 2<br />
N<br />
N<br />
O O<br />
Me Me<br />
diastereoselection 65:35<br />
HO<br />
F<br />
1) LiN 3/DMF; 93%<br />
2) hv; H + /H 2O;<br />
NaBH 4; 26%<br />
N<br />
O N<br />
O O<br />
Me Me<br />
NH 2<br />
Moffatt, J. G., et al, J. Am. Chem.Soc., 1976, 98, 3346-3357.<br />
N<br />
N
The Biogenic Origin of <strong>Halogen</strong>ated <strong>Natural</strong> <strong>Products</strong><br />
• Chlorine is incorporated by nucleophilic displacement as Cl - or through the reactions of alkenes <strong>with</strong><br />
chloroperoxidases (CPO's), ie as "Cl + "<br />
• Bromine is almost exlusively incorproated as "Br + " by bromoperoxidases (BrPO's)<br />
• Iodoperoxidases have been identified, but not studied in as much detail as CPO and BrPO<br />
As a result, most halogen-bearing stereogenic centers occur as halohydrins or polycyclics!<br />
"Br + "<br />
Me<br />
Me<br />
R<br />
R'<br />
"X + "<br />
Nu<br />
R<br />
+<br />
X<br />
R'<br />
Nu = H 2O, X - , ROH, C=C<br />
Examples of <strong>Halogen</strong> Biosynthesis<br />
HO Cl<br />
Me Me<br />
Br +<br />
epoxidation<br />
Cl<br />
Laurencenyne Prerogioloxepane<br />
- attack<br />
HO Cl<br />
O<br />
Br H H Cl<br />
Rogioloxepane C<br />
shaw 07/08 2/4/02 1:58 PM<br />
Me<br />
Me<br />
Me<br />
Geranyllinalool<br />
H<br />
OH<br />
O<br />
H<br />
O<br />
Br H H Cl<br />
Rogioloxepane B<br />
Isolated from Laurencia microcladia<br />
Br<br />
Me<br />
R<br />
Me<br />
Nu<br />
X<br />
R'<br />
Me<br />
O<br />
Br H H Cl<br />
Rogioloxepane A<br />
Me<br />
Me<br />
3-Bromobarekoxide<br />
isolated from Laurencia luzonensis<br />
O<br />
Pietra, F., et al, Helv. Chim. Acta, 1992, 75, 310-322<br />
Jefford, C. W. Chem. Commun., 2000, 1155-1156
Examples of <strong>Halogen</strong> Biosynthesis<br />
• The vast majority of the natural products herein discussed are isolated from the seaweeds (algae)<br />
of the genus Laurencia and Plocamium.<br />
• Sea hares of the species Aplysia that feed on the seaweed are also sources of the natural products<br />
and can modify them<br />
Laurencia seaweed<br />
V-BrPO=<br />
Vanadium<br />
Bromoperoxidase<br />
H-CPO=<br />
Heme-<br />
Chloroperoxidase<br />
shaw 09/10 2/4/02 2:00 PM<br />
Br<br />
Me<br />
Br<br />
HO<br />
Me<br />
Me Me<br />
Me<br />
O<br />
Me<br />
OH<br />
Me<br />
Br<br />
Cl<br />
Aplysia sea hare<br />
Br<br />
Br<br />
Me<br />
Me Me<br />
O<br />
Me<br />
Me<br />
Br<br />
Cl<br />
O Me<br />
+<br />
Br<br />
Cl<br />
Me<br />
Me<br />
Me Me<br />
O<br />
Me<br />
Br<br />
Cl<br />
Faulkner, D. J., et al, Comp. Biochem. Physiol., 1974, 49B, 37-41<br />
Haloperoxidases Catalyze Selective Oxidations<br />
AcO<br />
Ph<br />
n-Bu<br />
S Me<br />
V-BrPO/<br />
H2O2 pH 6.5<br />
25 °C<br />
O -<br />
S +<br />
Me<br />
S S +<br />
Me<br />
Ph Me<br />
H-CPO/<br />
H2O2 pH 5.5<br />
25 °C<br />
Ph<br />
n-Bu<br />
O<br />
O -<br />
Me<br />
O<br />
Me Me<br />
OH<br />
Me<br />
H-CPO/<br />
H2O2 pH 5.5<br />
25 °C<br />
AcO<br />
OH<br />
Me<br />
Yield (%) ee (%)<br />
6 0<br />
99 89<br />
67 96<br />
78 96<br />
52 95<br />
Ph Me 20 90<br />
Sulfoxidation: Allenmark, A., et al, J. Org. Chem., 1997, 62, 8455-8458<br />
Epoxidation: Hager, L. P. & Jacobsen, E. N., et al, J. Am Chem. Soc., 1993, 115, 4415-4416<br />
Propargylic Oxidation: Hager, L. P. & Hu, S., J. Am. Chem. Soc., 1999, 121, 872-873<br />
Benzylic Oxidation: Zaks, A., et al, J. Am. Chem. Soc., 1995, 117, 10419-10424
Haloperoxidases Catalyze Unselective Bromohydrin Formation<br />
OH<br />
Me<br />
OH<br />
OH<br />
Me<br />
OH<br />
Br<br />
Br<br />
(+/-) (+/-)<br />
H-CPO, Br - , H2O2 H-LPO, Br<br />
61% 39%<br />
- , H2O2 V-BrPO, Br<br />
- -<br />
- N-Bromoacetamide 75% 25%<br />
, H2O2 66% 34%<br />
H-CPO=Heme-dependent chloroperoxidase from Caldariomyces Fumago (fungus)<br />
H-LPO=Heme-dependent lactoperoxidase (haloperoxidase) from bovine milk<br />
V-BrPO=Vanadium-dependent bromoperoxidase from Corallina Officinalis (marine algae)<br />
"One of the most interesting, yet unsolved problems in the area of<br />
marine biohalogenation, is the biogenesis of the chiral<br />
halogenated marine natural products."<br />
Butler, A. Chem. Rev., 1993, 93, 1937–1944.<br />
"All haloperoxidases catalyze smooth, yet unselective<br />
chlorination, bromination or iodination of relatively electron-rich<br />
groups in organic compounds...However, there must be more<br />
stereo- and/or regioselective halogenating enzymes in nature,<br />
regarding the presence of halometabolites like 44 and 45."<br />
Franssen, M. C. R., Catalysis Today, 1994, 22, 441-457<br />
Me<br />
Me<br />
shaw 11/12 2/4/02 2:01 PM<br />
Br<br />
Br<br />
Cl<br />
Me<br />
H<br />
O<br />
Br<br />
C<br />
OH<br />
Coughlin, P., et al, Biotechnology Letters, 1993, 15, 907-912<br />
Enzyme-Catalyzed Bromohydrin Formation<br />
HO<br />
Laurediol<br />
O<br />
H<br />
Br<br />
OH<br />
OH<br />
E-Prelauretin<br />
Lactoperoxidase;<br />
NaBr, H 2O 2, pH 5.5<br />
0.05% Yield<br />
(0.41% BORSM)<br />
Lactoperoxidase;<br />
NaBr, H2O2, pH 5.5<br />
0.03% Yield<br />
(0.19% BORSM)<br />
Me<br />
Me<br />
Me<br />
O<br />
H<br />
Me Me<br />
H<br />
Cl Cl<br />
44 45<br />
O<br />
H<br />
Br<br />
O<br />
H<br />
Br<br />
OH<br />
E-Prelauretin<br />
O<br />
Laurallene<br />
Murai, A., et al:<br />
Tetrahedron Lett., 1995, 36, 737-740<br />
Tetrahedron, 1997, 53, 8371<br />
Cl<br />
Br<br />
H<br />
Cl
HN<br />
HN<br />
R<br />
Nucleophilic Displacement:<br />
OR<br />
R R'<br />
O<br />
R'<br />
Br -<br />
-or-<br />
CBr4/PR3 LA/Br -<br />
Methods of <strong>Halogen</strong>ation<br />
R<br />
Br<br />
R R'<br />
Bromoetherification/ Oxymercuration-Bromination<br />
Me<br />
O<br />
O<br />
Me<br />
Me<br />
OH<br />
Hg(OTF) 2<br />
Me<br />
CCl 3<br />
CCl 3<br />
OH<br />
"Br + "<br />
O<br />
TfHg<br />
Me Me<br />
R 1<br />
O<br />
Br<br />
Br<br />
OH<br />
O<br />
R'<br />
Me Me<br />
LiBr; Br2<br />
Br<br />
O<br />
Me Me<br />
Methods of <strong>Halogen</strong>ation<br />
CCl 3<br />
M = Cu, Fe, Ru, Mo<br />
CuCl/BiPy<br />
61%<br />
CuCl/BiPy<br />
98%<br />
shaw 13/14 2/4/02 2:02 PM<br />
R 1<br />
O<br />
HN<br />
Cl Cl<br />
HN<br />
Cl<br />
R 2<br />
O<br />
The Kharasch Reaction:<br />
R 2<br />
Cl<br />
Cl<br />
Cl<br />
O<br />
Cl<br />
Cl<br />
Cl<br />
M n<br />
Me<br />
O<br />
M n+1 Cl<br />
Me<br />
O<br />
O<br />
Me<br />
O<br />
O<br />
Me<br />
O<br />
R<br />
R<br />
R'<br />
R 1<br />
R 1<br />
CCl 3<br />
Cycloaddition/Sigmatropic<br />
Rearrangement:<br />
Cl<br />
O<br />
O<br />
Br<br />
OH<br />
Cl<br />
Cl Cl<br />
Cl<br />
R 2<br />
R<br />
R' Br<br />
R Cl<br />
O<br />
Polyene Cyclization<br />
Br<br />
R 2<br />
Me<br />
Me<br />
R 2<br />
R 3<br />
Me<br />
Hg(OTFA) 2, etc<br />
or Br +<br />
Me<br />
Me<br />
Me<br />
O<br />
CuCl/BiPy<br />
74%<br />
O<br />
O<br />
O<br />
Me<br />
O<br />
Me<br />
R<br />
R<br />
O<br />
Cl<br />
OMe<br />
Cl<br />
Cl<br />
Weinreb, S. M., et al, Tetrahedron, 1988, 44, 4671-4678<br />
Itoh, K., et al, J. Org. Chem, 1993, 58, 464-470<br />
Speckamp, W. N., et al, Synlett, 1993, 739
O<br />
H<br />
O H<br />
Br<br />
PMBO<br />
Me OH<br />
EtO 2C<br />
Me<br />
O O<br />
X<br />
O O<br />
shaw 15/16 2/4/02 2:03 PM<br />
O<br />
Br<br />
MsO<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
T. Masamune's Prepinnaterpene & Oppositol<br />
Me<br />
BnO H<br />
Me OH<br />
Me<br />
OBn<br />
OBn<br />
Bu 4NBr, 100 °C<br />
55% (35% alkene)<br />
OBn<br />
OTBS<br />
CO 2Et<br />
Me<br />
2 steps<br />
92%<br />
HO<br />
MsO BnO<br />
MeLi<br />
100%<br />
Br<br />
Me<br />
H<br />
Me<br />
CHO<br />
Br<br />
Me<br />
OBn<br />
Me<br />
O<br />
Bu 4NBr<br />
100 °C<br />
H<br />
Br<br />
OBn<br />
PPTs<br />
HO<br />
Br<br />
Me<br />
H<br />
Me<br />
96%<br />
Oppositol<br />
BnO<br />
63%<br />
Me<br />
Me<br />
Br<br />
Me<br />
OBn<br />
Br -<br />
3 steps<br />
95%<br />
Br<br />
Me<br />
BnO<br />
H<br />
HO Me Me<br />
Prepinnaterpene<br />
Me<br />
Me<br />
Me<br />
Br<br />
10%<br />
OBn<br />
(+ 20% alkene)<br />
Masamune, T., et al, Tetrahedron Lett, 1987, 28, 4303-4306<br />
Synthesis of Prepinnaterpene & Oppositol:<br />
Improved Core Syntheses<br />
PdCl 2(BINAP)<br />
Me<br />
86%ee<br />
X=I, OTf<br />
Me<br />
PMBO<br />
5 steps<br />
TBSO<br />
EtO 2C<br />
PMBO<br />
H<br />
O O<br />
Oppositol<br />
Me<br />
EtO 2C<br />
O O<br />
Me<br />
ds = "excellent"<br />
O<br />
H<br />
Me<br />
Br<br />
KOt-Bu<br />
PMBO<br />
KO<br />
OBn<br />
O<br />
H<br />
Masamune<br />
Intermediate<br />
EtO<br />
EtO 2C<br />
O O<br />
Me<br />
O<br />
Me<br />
OBn<br />
Shibasaki, M., et al, Tetrahedron Asymm, 1995, 28, 757-766<br />
Kim, D., et al, Tetrahedron Lett, 1997, 38, 415-416<br />
Br<br />
Me<br />
Br<br />
KHMDS<br />
Br<br />
Br<br />
O OPMB
Me<br />
Me<br />
O<br />
Me<br />
Me<br />
Me<br />
OsO 4<br />
83%<br />
Me<br />
O<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Iwata's Laurencial<br />
OH<br />
Me<br />
Me<br />
Me<br />
diastereoselection 95:5<br />
Me<br />
HO<br />
8 steps<br />
Me<br />
Br<br />
Me<br />
PivO<br />
O<br />
O<br />
Me<br />
shaw 17/18 2/4/02 2:05 PM<br />
Me<br />
Br<br />
B<br />
A<br />
OH<br />
O<br />
Me<br />
OH<br />
MeMgI<br />
81%<br />
SOCl 2,<br />
ZnCl 2<br />
81%<br />
87%<br />
OH<br />
MeO OMe<br />
Me<br />
Me<br />
Me Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
O<br />
Me<br />
Me<br />
O<br />
O<br />
Cl<br />
Me<br />
O<br />
Me<br />
Me<br />
Me<br />
O<br />
O<br />
Me<br />
Me<br />
Me<br />
O O<br />
O<br />
Br<br />
O<br />
Br<br />
Me<br />
PPTs<br />
O<br />
O3, MeOH<br />
pTSA<br />
46%<br />
A: diastereoselection >95:5<br />
B: diastereoselection 70:30<br />
Synthesis of Dactylyne<br />
Murai's regioselective epoxy alcohol opening:<br />
O<br />
R OH<br />
R<br />
Br<br />
OTBS<br />
O<br />
O<br />
OBz<br />
OMPM<br />
OH<br />
Ti(Oi-Pr) 4/<br />
Et 2NH-HX<br />
OR<br />
Et 2AlCl/<br />
Et 2NH-HX<br />
Ti(Oi-Pr) 4/<br />
Et2NH-HBr 78%<br />
O<br />
Me<br />
OHC<br />
1) MsCl<br />
2) DBN<br />
73%<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
O<br />
Cl<br />
O<br />
(+/-)-Laurencial<br />
Br<br />
Me<br />
O<br />
89%<br />
O<br />
Me<br />
O<br />
H<br />
O<br />
Me<br />
OH<br />
Me<br />
Me<br />
Iwata, C, et al, Tetrahedron, 1998, 54, 1396-1406<br />
R OH<br />
R<br />
HO<br />
X<br />
X<br />
HO<br />
HO<br />
see also Sharpless, K. B., et al, J. Org. Chem., 1985, 50, 15571560<br />
Cl<br />
Cl<br />
HO<br />
OMs<br />
OH<br />
Et 2AlCl<br />
90-100%<br />
E = Dactylyne<br />
Z = Isodactylyne<br />
PivO<br />
OH<br />
Br<br />
Br<br />
OTBS<br />
OH<br />
O<br />
OBz<br />
OMs<br />
OMPM<br />
OH<br />
Murai, A, et al, Tetrahedron Lett, 1992, 33,<br />
4349-4352
TMS<br />
TBDPSO<br />
TMS<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong><br />
• Before the 1988 synthesis of Laurenyne by Overman, there was only one synthesis<br />
of an oxocane-containing natural product known, ie T. Masumune's synthesis of Laurencin in<br />
0.003% yield.<br />
• In the last decade, however, many syntheses of medium-ring ether natural products from the<br />
Laurencia series have appeared.<br />
OH<br />
shaw 19/20 2/4/02 2:07 PM<br />
O<br />
H<br />
OAc<br />
Br<br />
Me<br />
Laurencin<br />
Principle Synthetic Challenges:<br />
1) medium ring formation<br />
2) diastereoselectivity across ring<br />
3) regiochemical control of unsaturation<br />
O<br />
Cl<br />
Laurenyne<br />
Overman's Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Laurenyne<br />
O<br />
SAD<br />
Cl<br />
OTs<br />
TMS<br />
single diastereomer<br />
SnCl 4<br />
37%<br />
OH<br />
10 steps<br />
Me<br />
O<br />
TBDPSO<br />
TMS<br />
Et 3NHCl/<br />
Ti(Oi-Pr) 4<br />
68%<br />
O<br />
O<br />
Cl<br />
OEt<br />
Cl<br />
OTs<br />
Laurenyne<br />
TMS OH TMS Cl<br />
+<br />
OH<br />
Cl<br />
HO<br />
OH<br />
regioselectivity 25:75<br />
TsCl/Pyr<br />
86%<br />
OTBDPS<br />
EtO<br />
PPTs TMS Cl<br />
98%<br />
HO<br />
20 Steps, 0.6% yield<br />
Absolute Configuration<br />
Reassigned<br />
OTs<br />
Overman, L. E., et al, J. Am. Chem. Soc., 1988, 110, 2248-2256
PivO<br />
i-Pr 3Si<br />
MeO<br />
PhS<br />
OMe<br />
Me<br />
O<br />
OSEM<br />
OH<br />
Overman's Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Laurencin<br />
O<br />
H<br />
n-BuLi;<br />
(-)-Ipc2BOMe; OH<br />
EtCHO<br />
70% yield<br />
92% ee OSEM<br />
OAc<br />
Me<br />
13 Steps<br />
O<br />
H<br />
OAc<br />
PhS<br />
SnCl4 57%<br />
5g scale<br />
PivO<br />
OH<br />
Me<br />
1) Br2/DPPE 2) TBAF<br />
40%<br />
Me<br />
O<br />
1) TBSOTf<br />
2) 9-BBN<br />
3) Pd(PPh 3) 4<br />
OMe<br />
SPh<br />
OAc<br />
Br<br />
Me<br />
87% for<br />
3 steps<br />
OSEM<br />
OAc<br />
80%<br />
O<br />
H<br />
OAc<br />
Br<br />
Me<br />
SPh<br />
SPh<br />
Laurencin<br />
OTBS<br />
OSEM<br />
O<br />
OSEM<br />
Me<br />
1) TBAF 2)<br />
OMe /DIPEA<br />
Br<br />
OPiv<br />
MeO<br />
Me<br />
24 steps/2% yield<br />
OPiv<br />
Overman, L. E., et al, J. Am. Chem. Soc., 1995, 117, 5958-5966<br />
Overman's Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Isolaurepinnacin<br />
O<br />
1) PhSO2Cl 2) Et2AlCl/ Et2NH2Br 94%<br />
OSO2Ph OH<br />
Br<br />
MeLi<br />
91%<br />
Me Me Me<br />
OTIPS<br />
O<br />
H<br />
Br<br />
H<br />
Cl<br />
(+)-Isolaurepinnacin<br />
12 steps/15% Yield<br />
shaw 21/22 2/4/02 2:08 PM<br />
(R)-BINAl-H<br />
5 steps/<br />
49%<br />
MeO<br />
Me<br />
OMe<br />
OH<br />
O<br />
Br<br />
OTIPS<br />
O<br />
H<br />
Br<br />
H<br />
Cl<br />
diastereoselection >95:5<br />
SiMe 3 Et 2AlCl<br />
SnBu 3<br />
88%<br />
MeO<br />
Br<br />
Cl<br />
1) BCl3 OH 2) TBAF<br />
Me<br />
90%!<br />
Me<br />
5 steps<br />
total<br />
Overman, L. E., et al, J. Am. Chem. Soc., 1993, 115, 9305-9306<br />
Br<br />
Br<br />
OH<br />
OTIPS<br />
O<br />
SiMe 3<br />
OMe<br />
Cl<br />
SiMe 3<br />
AgOTf/<br />
DIPEA<br />
95%<br />
OTIPS
TMS<br />
MeO<br />
Murai's Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Laurencin<br />
OTBS Me<br />
+ Me O<br />
O<br />
O Br<br />
A B<br />
regioselection<br />
7:1<br />
O<br />
Me O<br />
Si<br />
Me<br />
H<br />
O<br />
Si<br />
OH<br />
O<br />
OH<br />
Pt<br />
O<br />
O<br />
H<br />
OAc<br />
OH<br />
Me<br />
Li°<br />
77%<br />
O<br />
H<br />
OAc<br />
OH<br />
thermodynamic<br />
control, 12:1<br />
1) CBr 4/Oct 3P; 87%<br />
2) TBAF-HF/97%<br />
Br<br />
OTBS<br />
PivO<br />
Me<br />
O<br />
Laurencin<br />
Me<br />
O<br />
O<br />
Me<br />
O<br />
1) TBAF/95%<br />
2) SO 3-Pyr/86%<br />
Pb(OAc) 4<br />
92%<br />
O<br />
27 steps from A & B<br />
2.5% yield<br />
PivO<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Holmes & Clark's Laurencin<br />
OTBDPS<br />
OTBDPS<br />
diastereoselection<br />
3.5:1<br />
shaw 23/24 2/4/02 2:12 PM<br />
Me Me<br />
Si<br />
Si<br />
O<br />
Me Me<br />
O<br />
= "Pt(DVS) 2<br />
O<br />
OTBDPS<br />
OTBDPS<br />
HO<br />
O<br />
O<br />
diastereoselection >95:5<br />
KOH/H2O2 HO<br />
65%<br />
HO<br />
O<br />
OTBDPS<br />
OH<br />
O<br />
1) pTSA<br />
2) PivCl<br />
85%<br />
OH<br />
O OH<br />
Me<br />
Me<br />
O<br />
Murai, A., et al, Tetrahedron Lett, 1992, 4345-4348<br />
O<br />
OTBDPS<br />
O<br />
74%<br />
KHMDS<br />
(2R,8αS)-CSO<br />
Me<br />
Me<br />
N<br />
O S<br />
O<br />
O<br />
Br<br />
Me<br />
O<br />
O<br />
O<br />
OTBDPS<br />
O<br />
O<br />
H<br />
O<br />
OAC<br />
Laurencin<br />
OTBDPS<br />
26 steps<br />
0.4% yield<br />
Holmes, A. B., et al, J. Am. Chem. Soc., 1993, 115, 10400-10401.
O<br />
HO<br />
O<br />
1<br />
O<br />
OTBDPS<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Holmes & Clark's Laurencin - Retraction!<br />
KHMDS<br />
(2R,8αS)-CSO<br />
HO<br />
HO<br />
O<br />
O<br />
O<br />
O<br />
OTBDPS<br />
OTBDPS<br />
Br<br />
Me<br />
O<br />
H<br />
OAC<br />
Laurencin<br />
"The synthesis of lactone 1 as reported by J. S. Clark, Ph. D. Thesis, Cambridge University,<br />
1988, is correct. The synthesis of (+)-laurencin in ref 1 is difficult to account for and must<br />
probably be charged to the fallibility of the other junior author and the gullibility of the senior<br />
author."<br />
Holmes, A. B., et al, J. Am. Chem. Soc., 1996, 118, 6806.<br />
OH<br />
O<br />
(R)-Malic Acid<br />
OH<br />
shaw 25/26 2/4/02 2:13 PM<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Holmes & Clark's Laurencin - Retooled<br />
HO<br />
O<br />
Br - PPh 3 +<br />
OH<br />
• Use of various oxidants in the enolate oxidations<br />
failed to provide acceptable yields or selectivities<br />
O<br />
O<br />
OTBDPS<br />
• Route was abandoned and the correct diastereomer<br />
of hydroxy-lactone was prepared from malic acid<br />
• Stereochemical assignments were carefully monitored<br />
en route to laurencin<br />
O<br />
H<br />
Me<br />
O<br />
O<br />
Me<br />
HO<br />
Various [O]<br />
Bad<br />
Reaction!<br />
Br<br />
Me<br />
O<br />
HO<br />
OH<br />
O<br />
O<br />
H<br />
O<br />
OAC<br />
Laurencin<br />
Me<br />
O<br />
Me<br />
O<br />
OTBDPS<br />
Holmes, A. B., et al, J. Am. Chem. Soc., 1997, 119, 7483-7498
HO<br />
Me<br />
O<br />
O<br />
(+)-DET<br />
+<br />
Me<br />
O<br />
O OTBS<br />
12<br />
steps<br />
Cl<br />
Me<br />
shaw 27/28 2/4/02 2:15 PM<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Murai's Obtusenyne<br />
Cl<br />
1) n-BuLi<br />
2) Lindlar's Cat.<br />
OTBS<br />
89%<br />
O O<br />
Cl<br />
O OTBS<br />
HO<br />
Me<br />
diastereoselection<br />
2:1<br />
EtMgBr<br />
CuI<br />
DMDO; DIBALH<br />
71%<br />
Cl<br />
TfO<br />
O OTBS<br />
O<br />
OH<br />
Cl<br />
Br<br />
Me<br />
Cl<br />
OTBS<br />
OTBS<br />
KHMDS/<br />
PhNTf 2<br />
O<br />
(+)-Obtusenyne<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Suzuki's Rogioloxepane A<br />
OBn<br />
OTBS<br />
BnO OH<br />
H H<br />
Me O<br />
OMPM<br />
+<br />
Me<br />
O<br />
11steps<br />
OMPM<br />
OTBS<br />
Br<br />
H H<br />
Cl<br />
O<br />
O O<br />
Cl<br />
O<br />
O<br />
Cl<br />
OH<br />
OTBS<br />
Cl<br />
OTBS<br />
Murai, A., et al, J. Org. Chem., 1999, 64, 2616-2617<br />
n-BuLi/<br />
OBn<br />
BF3•OEt2 Me<br />
78% OTBS<br />
(Bu 3Sn) 2O;<br />
Zn(OTf) 2<br />
75%<br />
Me<br />
(+)-Rogioloxepane<br />
OBn<br />
OH<br />
O<br />
OH<br />
27 steps/5% yield<br />
Absolute Configuration<br />
Confirmed<br />
OMPM<br />
OTBS<br />
OMPM<br />
Suzuki, T., et al, Tetrahedron Lett., 2001, 42, 1543-1546
BnO<br />
N O<br />
BnO<br />
Me<br />
O<br />
H<br />
H<br />
O O<br />
diastereoselection >95:5<br />
BnO<br />
Me<br />
BnO<br />
Me<br />
BnO<br />
O<br />
H<br />
H<br />
+<br />
O<br />
Bn<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Crimmins' Laurencin<br />
O<br />
Bn<br />
N<br />
O<br />
(Cy 3P) 2RuCl 2CHPh<br />
94%<br />
Bn<br />
H<br />
O<br />
Bn<br />
O<br />
N<br />
N<br />
TESO OAc<br />
Me<br />
Me<br />
O<br />
O<br />
O<br />
7 steps<br />
49%<br />
TESO O<br />
shaw 29/30 2/4/02 2:23 PM<br />
H<br />
O<br />
I<br />
O<br />
O<br />
O<br />
NaHMDS/<br />
Allyl-I<br />
71%<br />
NaHMDS/<br />
Allyl-I<br />
75%<br />
Br<br />
Me<br />
BnO<br />
Me<br />
BnO<br />
O<br />
N<br />
O<br />
O<br />
Bn<br />
diastereoselection >95:5<br />
H<br />
O<br />
Bn<br />
O<br />
O<br />
H<br />
OAc<br />
Laurencin<br />
N<br />
O<br />
O<br />
PivCl/Et3N LiXp 76%<br />
HO 2C<br />
OBn<br />
18 Steps/6% yield<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Crimmins' Isolaurallene<br />
O<br />
OSO 2Ar<br />
NaHMDS<br />
75%<br />
(Cy 3P) 2RuCl 2CHPh<br />
OH<br />
94%<br />
LiCuBr2 67%<br />
BnO<br />
Me<br />
BnO<br />
TESO<br />
Me<br />
H<br />
O<br />
H<br />
O<br />
Bn<br />
O<br />
N<br />
TESO<br />
Me<br />
O<br />
O<br />
H<br />
H<br />
OH<br />
O<br />
OBn<br />
Me<br />
BrCH 2CO 2H<br />
NaH; 88%<br />
Me<br />
Crimmins, M. T., et al, Org. Lett., 1999, 1, 2029-2032<br />
O<br />
OAc<br />
O<br />
C<br />
O<br />
NaBH4; Swern<br />
83%<br />
4 steps<br />
OH<br />
65%<br />
BnO<br />
O<br />
Me H<br />
BnO<br />
Me<br />
H<br />
O<br />
CHO<br />
OAc<br />
PPTs/MeOH<br />
CBr4/Oct3P 58%<br />
Br<br />
Br<br />
Me<br />
O<br />
O<br />
H<br />
H<br />
(-)-Isolaurallene<br />
C<br />
OBn<br />
1) (4- d Icr) 2BCH 2CHCH 2<br />
2) Ac 2O; 93%<br />
OBn<br />
Crimmins, M. T., et al, J. Am. Chem. Soc., 2001, 123, 1533-1534<br />
Br
O<br />
PMBO CO 2Et<br />
Br<br />
Me<br />
year<br />
Overman 1995<br />
Murai 1992<br />
Holmes 1997<br />
Boeckman 2001<br />
Crimmins 1999<br />
shaw 31/32 2/4/02 2:23 PM<br />
O<br />
OPMB<br />
CO 2Et<br />
O<br />
H<br />
Boeckman's Laurencin<br />
1) CBS<br />
Reduction<br />
2) PhCOCl<br />
82%<br />
78%<br />
8 steps<br />
O<br />
O<br />
H<br />
H<br />
O<br />
OPMB<br />
Murai<br />
Intermediate<br />
O<br />
PMBO CO2Et Me<br />
O<br />
PMBO<br />
98% ee<br />
9 steps<br />
1) LiAlH 4<br />
2) Dess-<br />
Martin<br />
Br<br />
CO 2Et<br />
Me<br />
O<br />
H<br />
KHMDS<br />
76%<br />
MeO 2C<br />
MeO 2C<br />
PMBO<br />
OAC<br />
Laurencin<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Summary<br />
O<br />
H<br />
OAc<br />
Laurencin<br />
ds<br />
across ring<br />
>95:5<br />
92:8<br />
58:42<br />
-<br />
>99:1<br />
Principle Synthetic Challenges:<br />
1) Medium Ring Ether Formation<br />
2) Alkene Regiochemistry<br />
3) Diastereoselectivity<br />
rs<br />
of alkene #steps %yield<br />
>95:5<br />
88:12<br />
>95:5<br />
-<br />
>95:5<br />
24<br />
>27 (30)<br />
>28<br />
22<br />
18<br />
2<br />
2.5<br />
1.2<br />
4<br />
6<br />
Boeckman, R. K. Jr., et al, Unpublished Results<br />
comments<br />
good ds, general route<br />
*first, but not best<br />
good if claisen route panned out...<br />
Good 8-membered ring synthesis<br />
high yielding, general, but uses<br />
oxazolidinone auxiliary at 3 stages of<br />
the synthesis<br />
*"first" post-masamune
O<br />
Cl<br />
"Br + "<br />
Cl<br />
OH<br />
OH<br />
TMSO<br />
AcO<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Kumausyne & Kumausallene<br />
Me<br />
H<br />
H<br />
O<br />
H<br />
Br<br />
- HOAc<br />
H<br />
O<br />
H<br />
Br<br />
Kumausyne Kumausallene<br />
O<br />
O<br />
Br<br />
Cl<br />
(+/-)-trans-maneonene-B<br />
Holmes, A. B., et al, Chem Comm, 1984, 1594-1595.<br />
Me<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Overman's Kumausyne<br />
O<br />
H<br />
BnOCH2CHO RSO3H 69% O<br />
H<br />
H<br />
O<br />
H<br />
OTBS<br />
(EtO) 2P(O)CLiCl2 88%<br />
TMSO<br />
O<br />
H H<br />
OTBS<br />
n-BuLi<br />
88%<br />
TMSO<br />
shaw 33/34 2/4/02 2:24 PM<br />
O<br />
H H<br />
OTBS<br />
Me<br />
Me<br />
Me<br />
O<br />
OBn<br />
H<br />
O<br />
H<br />
Br<br />
AcO<br />
C<br />
mCPBA<br />
72%<br />
O<br />
O<br />
H<br />
O<br />
OBn<br />
+<br />
O<br />
O<br />
H<br />
O<br />
H<br />
H<br />
14%<br />
58%<br />
O<br />
H<br />
OH<br />
73%<br />
diastereoselection >95:5<br />
4 steps<br />
Me<br />
H<br />
O<br />
SiMe 3<br />
BF 3•OEt 2<br />
H<br />
O<br />
H<br />
Br<br />
(+/-)-Kumausyne<br />
Me<br />
O<br />
Me<br />
O<br />
H<br />
O<br />
H<br />
58%<br />
Me<br />
OBn<br />
CHO<br />
Overman, L. E., et al, J. Am. Chem. Soc., 1991, 113, 5378-5384
MeO<br />
R<br />
O<br />
OTHP<br />
OTHP<br />
OH<br />
O<br />
OMe<br />
TBDPSO<br />
TBDPSO<br />
TBDPSO<br />
shaw 35/36 2/4/02 2:25 PM<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Boukouvalas Kumausyne<br />
5 steps<br />
TMS<br />
HO OH<br />
HO<br />
AcO<br />
O<br />
OTBDPS<br />
5 steps<br />
OTBDPS<br />
H<br />
O<br />
H<br />
Br<br />
(+/-)-Kumausyne<br />
PdCl2(0.1 equiv)<br />
CuCl2(3 equiv)<br />
CO, NaOAc, HOAc<br />
93%<br />
TMS<br />
P + Ph3Br -<br />
93%<br />
91:9 E:Z<br />
Me<br />
O<br />
HO<br />
O<br />
O<br />
O<br />
O<br />
DIBAL-H<br />
100%<br />
Sugimura<br />
Intermediate<br />
OTBDPS<br />
OTBDPS<br />
Boukouvalas, J., et al, J. Org. Chem., 1998, 63, 916-917<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Martín's Biomimetic synthesis of Kumausyne<br />
12 steps<br />
H<br />
OH<br />
O<br />
H H<br />
Br<br />
+<br />
1) TBCD<br />
2) HCl/MeOH<br />
92%<br />
O<br />
H H<br />
Br<br />
diastereoselection 50:50<br />
Me<br />
Me<br />
Me<br />
OH<br />
Br Br<br />
Br<br />
O<br />
TBCD<br />
Br<br />
11 steps<br />
OTHP<br />
OTHP<br />
TBDPSO<br />
TBDPSO<br />
HO<br />
H<br />
OH<br />
1) TBCD<br />
2) HCl/MeOH<br />
79%<br />
O<br />
H H<br />
Br<br />
diastereoselection 83:17<br />
7 steps<br />
H<br />
O<br />
H<br />
Br<br />
(+)-Deacetylkumausyne<br />
Me<br />
Me<br />
Me<br />
Martín, V. S., et al, J. Org. Chem., 1997, 62, 1570-1571
O<br />
TMS<br />
Br<br />
H<br />
O<br />
H<br />
O<br />
H<br />
kumausyne<br />
intermediate<br />
HO<br />
C<br />
OH<br />
O<br />
H<br />
H<br />
O<br />
H<br />
O<br />
H<br />
O<br />
OBn<br />
H<br />
H<br />
O<br />
O<br />
(+/-)-Kumausallene<br />
BnO<br />
Br<br />
OH<br />
Br<br />
O<br />
H<br />
HO<br />
Br<br />
OH<br />
Br<br />
shaw 37/38 2/4/02 2:30 PM<br />
H<br />
O<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Overman's Kumausallene<br />
OTBS<br />
H<br />
1) LHMDS/PhSeCl<br />
2) O3, Pyridine<br />
70%<br />
OTBS<br />
H Br<br />
Me<br />
Me<br />
Me<br />
O<br />
O<br />
H<br />
H<br />
1) DCC/DMAP<br />
2) Sb(SPh) 3<br />
78%<br />
1) Swern<br />
2) TiCl4; 78%; TMS Ti(Oi-Pr) 4<br />
Br<br />
H<br />
ds=84:16<br />
C<br />
H<br />
O<br />
O<br />
H H<br />
O<br />
Br<br />
H<br />
HON<br />
Me<br />
OBn<br />
C<br />
S<br />
NaOMe/<br />
MeOH<br />
83%<br />
diastereoselection<br />
>90:10<br />
S<br />
OSO 2Ar<br />
H<br />
O<br />
H<br />
O<br />
H<br />
HO 2C<br />
+<br />
H<br />
O<br />
H<br />
O<br />
H<br />
H<br />
MeO 2C<br />
O<br />
H<br />
OTBS<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Evans' Kumausallene<br />
1) TBS-Cl/Im.<br />
2) PBu3, CO2Me 97%<br />
OBn<br />
(TBCD)<br />
86%<br />
1) DIBAL-H<br />
- + 2) BrPh3 P<br />
3)TBAF<br />
diastereoselection 94:6<br />
BnO<br />
O<br />
BnO<br />
TMS<br />
diastereoselection 29:71<br />
OBn<br />
OTBS<br />
CO 2Me<br />
H<br />
O<br />
OTBS<br />
H<br />
O<br />
H<br />
O<br />
H<br />
OTBS<br />
Me<br />
LiBr 2Cu;<br />
73%<br />
H<br />
Me<br />
O<br />
OH<br />
Me<br />
Overman, L. E., et al, J. Org. Chem., 1993, 58, 2468-2477<br />
O<br />
H<br />
1) Jones [O]<br />
2) Et3N, Bu3P, PhSeBr<br />
57-74%<br />
O 1) K-Selectride<br />
2) PPTs<br />
84%<br />
Br<br />
H<br />
C<br />
H<br />
O<br />
BnO COSePh<br />
O<br />
CO2Me BnO<br />
O<br />
H H<br />
Br<br />
(-)-Kumausallene<br />
Et 3B, O 2,<br />
(TMS) 3SiH<br />
92%<br />
O<br />
O<br />
CO 2Me<br />
Evans, P. A., et al, Angew. Chem. Int. Ed., 1999, 38, 3175-3177<br />
Me
O<br />
HO<br />
HO<br />
H<br />
HO CO2Et EtO2C OH<br />
H<br />
MeO 2C<br />
Cl<br />
CCl 3<br />
O<br />
OH<br />
OH<br />
6 steps<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Lee's Kumausyne & Kumausallene<br />
Br<br />
8 steps<br />
H<br />
EtO 2C<br />
C<br />
MeO<br />
PhSe<br />
H<br />
O<br />
O<br />
H<br />
H<br />
O<br />
H<br />
O<br />
H<br />
O<br />
O<br />
H H<br />
Br<br />
Kumausallene<br />
I<br />
SePh<br />
CO 2Et<br />
CO 2Et<br />
Me<br />
Bu 3SnH, AIBN<br />
86%<br />
Bu 3SnH, AIBN<br />
86%<br />
13 steps<br />
MeO<br />
EtO 2C<br />
EtO 2C<br />
AcO<br />
O<br />
H<br />
CO2Et O<br />
H<br />
diastereoselection >95:5<br />
13 steps<br />
H<br />
O<br />
H<br />
Br<br />
Kumausyne<br />
O<br />
H<br />
H O<br />
9 Steps<br />
O<br />
H<br />
H O<br />
CO 2Et<br />
OH<br />
Overman Intermediate<br />
Me<br />
Lee, E, et al, Tetrahedron Lett, 1997, 38, 7757-7758<br />
Lee, E, et al, Tetrahedron Lett, 1998, 39, 317-318<br />
Synthesis of Aplysia <strong>Natural</strong> <strong>Products</strong>:<br />
Successful Application of Lee's Radical Methodology<br />
H<br />
O<br />
O<br />
H<br />
H<br />
(3Z)-Dactomelyne<br />
shaw 39/40 2/4/02 2:31 PM<br />
Diethyl Tartrate<br />
O<br />
Et<br />
Br<br />
7 steps;<br />
45%<br />
O<br />
Ph<br />
7 steps<br />
55%<br />
AIBN<br />
Cl<br />
Cy3SnH Cl<br />
67% MeO2C TBDPSO<br />
Cl<br />
H<br />
O<br />
O<br />
H<br />
H<br />
O<br />
O<br />
CO 2Me<br />
O<br />
H<br />
Br<br />
diastereoselection >95:5<br />
MeO 2C<br />
Cl<br />
Ph<br />
Et 3B<br />
TMS 3SiH<br />
98%<br />
AIBN<br />
Cy 3SnH<br />
67%<br />
Ph<br />
O<br />
O<br />
HSiR 3<br />
O<br />
TBDPSO<br />
Cl<br />
Lee, E, et al, J. Am. Chem. Soc. , 1995, 117, 8017-8017<br />
H<br />
O<br />
Ph<br />
MeO2C O<br />
H<br />
O<br />
diastereoselction 93:7<br />
Cl<br />
O<br />
H<br />
H<br />
9 steps<br />
40%<br />
O<br />
Br<br />
Br CO 2Me
L-arabinose<br />
TMS<br />
HO<br />
O<br />
3<br />
steps<br />
O<br />
TMS<br />
81%<br />
HO<br />
Overman<br />
Sugimura<br />
Lee<br />
Martín<br />
Boukoulavas<br />
shaw 41/42 2/4/02 2:33 PM<br />
Me<br />
O<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Sugimura's Kumausyne<br />
O<br />
Me<br />
O<br />
OTBDPS<br />
O<br />
Me<br />
PPh 3 + Br -<br />
OTBDPS<br />
CHO<br />
O<br />
Me<br />
DIBAL-H<br />
100%<br />
5 steps<br />
11%<br />
+ SiMe 2Ph BF 3•OEt 2<br />
O<br />
O<br />
AcO<br />
O<br />
OTBDPS<br />
H<br />
O<br />
H<br />
Br<br />
Kumausyne<br />
7 steps<br />
30%<br />
Me<br />
Me<br />
Me<br />
O<br />
O<br />
Me<br />
HO<br />
O<br />
O<br />
O<br />
Me<br />
Me<br />
12%<br />
O O<br />
Sugimura, H., et al, Tetrahedron Lett, 1995, 38, 5789-5792<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Summary of Kumausyne and Kumausallene<br />
AcO<br />
Br<br />
C<br />
H O<br />
Me<br />
H<br />
H<br />
O<br />
H<br />
Br<br />
H<br />
O<br />
H<br />
Br<br />
Kumausyne Kumausallene<br />
1991<br />
1995<br />
1997<br />
1997<br />
1998<br />
13/5.4<br />
16/1.3<br />
17/2.5<br />
21/13<br />
13/6.2<br />
Overman<br />
Lee<br />
Evans<br />
1993<br />
1998<br />
1998<br />
+<br />
Me<br />
O<br />
O<br />
SiMe 2Ph<br />
Me Me<br />
73%<br />
diastereoselection >95:5<br />
year #steps/%yield year #steps/%yield<br />
17/2<br />
29/0.4<br />
14/6<br />
Me
Br<br />
Me<br />
Me<br />
Cl<br />
Me<br />
O<br />
regioselection 33:66<br />
Me<br />
Synthesis of Aplysia <strong>Natural</strong> <strong>Products</strong>:<br />
Jung's Aplysiapyranoid D<br />
N SH<br />
Me +<br />
Cl<br />
OTBS<br />
Br<br />
+<br />
Cl<br />
O<br />
Me Me<br />
Br<br />
Cl<br />
4 steps<br />
Me<br />
O<br />
Me<br />
Me<br />
Me<br />
OTBS<br />
TBAF<br />
43% (two steps)<br />
Me<br />
O<br />
Me<br />
Me<br />
OH<br />
Me Me<br />
TBCD<br />
Cl<br />
Me<br />
1) Swern<br />
2) Cr2Cl2/CHCl3 77%<br />
OH<br />
Me<br />
Me<br />
OH<br />
Br<br />
SAE<br />
90%<br />
>95%ee<br />
Cl<br />
OTBS<br />
Me<br />
TBSCl<br />
Me<br />
O<br />
Me<br />
Me<br />
83%<br />
O<br />
Me Me<br />
Cl<br />
Aplysiapyranoid D<br />
Synthesis of Aplysia <strong>Natural</strong> <strong>Products</strong>:<br />
Jung's Aplysiapyranoids A & C<br />
OH<br />
Cl<br />
OH<br />
Me Me<br />
Me<br />
Me<br />
Me<br />
shaw 43/44 2/4/02 2:34 PM<br />
5 steps<br />
OH<br />
NH 4Br/DMSO<br />
Ti(OiPr) 4<br />
Br<br />
94%<br />
4 steps<br />
Br<br />
Me<br />
OH<br />
Me<br />
Me<br />
Cl<br />
OH<br />
Me<br />
OH<br />
Me<br />
Me<br />
Cl<br />
OH<br />
NH 4Cl/DMSO<br />
Ti(OiPr) 4<br />
84%<br />
Cl<br />
Me<br />
Me<br />
Me<br />
OH<br />
OH<br />
Jung, M. E., et al, J. Org. Chem., 1992, 56, 1347-1348<br />
1) Swern<br />
2) CrCl2/CHCl3 22%<br />
TBCD<br />
41%<br />
Br<br />
Br<br />
TBCD<br />
40%<br />
Me<br />
Me<br />
Me<br />
OH<br />
Me<br />
Me<br />
O<br />
Me<br />
Cl<br />
Aplysiapyranoid A<br />
Br<br />
Cl<br />
Me<br />
Jung, M. E., et al, Tetrahedron Lett., 1993, 34, 923-926<br />
Jung, M. E., et al, J. Org. Chem., 1998, 63, 2982-2987<br />
Br<br />
Cl<br />
Me<br />
O<br />
Me<br />
Cl<br />
Aplysiapyranoid C
Me<br />
Me<br />
Br<br />
Me<br />
Me<br />
Br<br />
E,E-<br />
Farnesol<br />
Geraniol<br />
O<br />
O<br />
Me<br />
Me<br />
7 steps<br />
22%<br />
shaw 45/46 2/4/02 2:36 PM<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Thyrsiferol & Venusatriol<br />
O<br />
Me<br />
O<br />
H<br />
Me OH Me<br />
OH<br />
O<br />
H<br />
Me<br />
OH<br />
Me<br />
Me<br />
Me<br />
O<br />
Me<br />
Me<br />
O<br />
H<br />
O<br />
Me OH Me<br />
OH<br />
O<br />
H<br />
Me<br />
OH<br />
Me<br />
(+)-Thysiferol Br<br />
(+)-Venusatriol<br />
Me<br />
Me<br />
"Br + "<br />
Me<br />
Me<br />
O<br />
H 2O<br />
Me<br />
O<br />
O<br />
H +<br />
Me<br />
Me<br />
O<br />
O<br />
Me<br />
Me Me<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Corey's Venusatriol<br />
Me<br />
HO<br />
O<br />
Me<br />
O<br />
CN<br />
TBCD<br />
Zn°/HOAc<br />
Br<br />
Me<br />
O<br />
CN<br />
O<br />
R<br />
+ Me<br />
Me<br />
O<br />
Me<br />
O<br />
H<br />
61%<br />
Br<br />
+<br />
epimer 5%<br />
26%<br />
DIBAL-H<br />
54%<br />
Me<br />
O CHO<br />
Me<br />
Me<br />
Me<br />
O<br />
O<br />
H<br />
Br A<br />
Me<br />
BnO<br />
OH<br />
H<br />
OH<br />
PCC<br />
Me 43%<br />
Me<br />
Me<br />
BnO<br />
O<br />
OH<br />
1) Swern<br />
H<br />
Me<br />
OH<br />
Me<br />
Br<br />
Me H<br />
Me<br />
O<br />
H<br />
Me<br />
O O<br />
t-BuLi; CeCl3; A<br />
85%<br />
O<br />
Me<br />
O<br />
H<br />
Me OH Me<br />
O<br />
H<br />
OH<br />
(+)-Venusatriol<br />
H<br />
Me<br />
OH<br />
Me<br />
2) MeMgBr<br />
3) TsOH/H2O 84%<br />
Me<br />
Me<br />
O<br />
Me<br />
O<br />
Me<br />
O<br />
H<br />
HO H<br />
H<br />
Me<br />
H<br />
O<br />
O<br />
H<br />
Me<br />
Me<br />
O<br />
diastereoselection >95:5 Br<br />
diastereoselection >95:5<br />
Corey, E. J., et al, Tetrahedron Lett., 1988, 26, 3171-3174
Me<br />
Me<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Shirahama and Forsyth Improve the Bromocyclization<br />
R OH "Br +"<br />
Me<br />
+ Br<br />
Me<br />
O<br />
Me<br />
R<br />
H<br />
Me<br />
OR<br />
+ Br<br />
Me<br />
Me<br />
R<br />
O<br />
Me<br />
H<br />
+ Br<br />
Me<br />
Me Me<br />
O H<br />
Me<br />
Me<br />
O<br />
Me<br />
R<br />
Me<br />
Me<br />
O<br />
Me<br />
R<br />
Me<br />
Br O<br />
Me<br />
R<br />
Shirahama<br />
Br Br<br />
Me<br />
R = H 80% 0% 20%<br />
R = 0% 10% 90%<br />
R =<br />
R =<br />
Me<br />
Me<br />
Forsyth<br />
OBz<br />
OBz<br />
NC OH<br />
shaw 47/48 2/4/02 2:37 PM<br />
47% 32% 21%<br />
12% 36% 52%<br />
• Bulky R favors correct diastereomer, but also favors THF formation<br />
Me<br />
Me<br />
CN<br />
Shirahama, H., et al, J. Org. Chem., 1990, 55, 5088-5107<br />
Forsyth, C. J., et al, J. Am. Chem. Soc, 2000, 122, 9099-9108<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Forsyth's Oxymercuration as an alternative<br />
Hg(TFA) 2<br />
KBr<br />
X<br />
X<br />
Hg<br />
Me<br />
O<br />
H<br />
Me<br />
OR<br />
X Me<br />
X<br />
X Hg<br />
Me<br />
X<br />
Hg<br />
O<br />
Me<br />
H<br />
CN<br />
Me Me<br />
Me Me<br />
Me O CN<br />
Me O CN<br />
BrHg BrHg<br />
100%<br />
(79% isolated)<br />
Me Me<br />
Me O R<br />
Br<br />
Br 2, Pyridine<br />
300 nm<br />
79%<br />
Me<br />
BrHg<br />
Me<br />
0% 0%<br />
Me<br />
Me<br />
R<br />
Me<br />
Me Me<br />
O H<br />
O<br />
CN<br />
Me<br />
CN<br />
NC OH<br />
Me<br />
Cannot Be Prepared<br />
Enantioselectively or<br />
Resolved!
Me<br />
Me<br />
Me<br />
Me<br />
Synthesis of Aplysia <strong>Natural</strong> <strong>Products</strong>:<br />
Hoye's Polycyclization<br />
Me<br />
OH<br />
Me HO Me<br />
Homogeraniol<br />
2 steps<br />
Me<br />
Br<br />
Me H<br />
Me<br />
Me<br />
O<br />
Me<br />
O<br />
Me<br />
H<br />
Br<br />
Me H<br />
Me<br />
(+/-)-Aplysistatin<br />
shaw 49/50 2/4/02 2:39 PM<br />
H<br />
O<br />
CO 2Et<br />
Me SPh CO2Me<br />
OBn<br />
SPh<br />
AgBF 4/Br 2<br />
Br<br />
Me<br />
1) Hg(TFA) 2<br />
2) KBr<br />
3) Br2, LiBr, pyr, O2 44%<br />
Me<br />
O<br />
H<br />
Me<br />
O<br />
+<br />
Br<br />
Me<br />
Me<br />
Me<br />
NPS =<br />
Me<br />
Me<br />
Me<br />
Me<br />
HO<br />
HO<br />
Synthesis of Aplysia <strong>Natural</strong> <strong>Products</strong>:<br />
White's Aplysistatin<br />
O<br />
O<br />
1) NPS*/Et 3N<br />
2) NaBH 4<br />
79%<br />
Me<br />
shaw 51/52 2/4/02 2:41 PM<br />
R<br />
O<br />
SPh O<br />
O<br />
O<br />
N<br />
SPh<br />
Hg(TFA) 2<br />
KBr<br />
Br 2, LIBr, O 2, pyr<br />
Br<br />
Me H<br />
Me<br />
Br<br />
Me H<br />
Me<br />
Me<br />
O<br />
Me<br />
O<br />
Br<br />
Me H<br />
Me<br />
Me<br />
O<br />
H<br />
O<br />
(+/-)-Aplysistatin<br />
O<br />
O<br />
Me<br />
O<br />
Br<br />
Me H<br />
Me<br />
13% 28%<br />
H<br />
26%<br />
O<br />
O<br />
SPh<br />
mCPBA/∆<br />
68%<br />
Corey's Use of Mercuriocyclization:<br />
Aphidicolin & Stemodinone<br />
CO2Me Me<br />
OPO(OEt) 2<br />
t-Bu<br />
Hg(OTFA) 2;<br />
NaCl<br />
60%<br />
R=H or R=OTBS<br />
O<br />
O<br />
HO<br />
HO<br />
+<br />
+<br />
O<br />
Br<br />
Me H<br />
Me<br />
Me<br />
O<br />
H<br />
7%<br />
O<br />
O<br />
O<br />
O<br />
SPh<br />
White, J. D., J. Am. Chem. Soc., 1982, 104, 3923-3928<br />
ClHg<br />
H<br />
Me<br />
R<br />
CO2Me Me<br />
O<br />
CO2Me CO2Me Me Me<br />
O<br />
O<br />
H<br />
Me<br />
Me H<br />
(+/-)-Aphidicolin<br />
O<br />
H<br />
Me<br />
O<br />
H<br />
Me<br />
Me<br />
Me H<br />
HO Me<br />
H<br />
(+/-)-Stemodinone<br />
Corey, E. J. et al, J. Am. Chem. Soc., 1980, 102, 1742-1744<br />
Corey, E. J. et al, J. Am. Chem. Soc., 1980, 102, 7612-7613
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
Br<br />
Me H<br />
Me<br />
Synthesis of Laurencia <strong>Natural</strong> <strong>Products</strong>:<br />
Nishizawa's Isoaplysin-20<br />
Me<br />
OAc<br />
(E, E)-Farnesyl Acetate<br />
Me<br />
OH<br />
Me<br />
H H<br />
1.8%<br />
(+/-)-Isoaplysin-20<br />
Hg(TFA) 2/PhNMe 2<br />
KBr; LiBr, Br 2, O 2<br />
OH<br />
NaOH/H 2O<br />
Nishizawa, M., et al, J. Am. Chem. Soc., 1984, 106, 4290-4291<br />
O<br />
PhSe<br />
O<br />
Me<br />
Br<br />
Me H<br />
Me<br />
Me<br />
Br<br />
Me H<br />
Me<br />
Me<br />
OH<br />
Me<br />
H H<br />
16%<br />
Me<br />
OH<br />
Me<br />
H H<br />
1.8%<br />
OAc<br />
OAc<br />
Synthesis of Plocamium <strong>Natural</strong> <strong>Products</strong>:<br />
The Diels-Alder approach<br />
Me CHO<br />
Tol/170 °C<br />
53%<br />
Me<br />
CHO<br />
Li<br />
Cl Cl<br />
diastereoselection 77:23<br />
+ CHClBr -<br />
+<br />
30%<br />
Me<br />
Cl<br />
Cl<br />
Zn/HOAc<br />
89%<br />
Me<br />
shaw 53/54 2/4/02 2:43 PM<br />
Cl<br />
Cl<br />
"10%"<br />
HO<br />
CH 2Br 2<br />
Zn°/TiCl 4<br />
64%<br />
Me<br />
PhSe<br />
Cl<br />
+ Z isomer<br />
Me<br />
Cl<br />
NBS<br />
Cl<br />
Zn/HOAc<br />
"100%"<br />
Cl<br />
NaOCl<br />
75%<br />
PhSe<br />
Cl<br />
Me<br />
+<br />
H<br />
Me<br />
Me Me<br />
Me<br />
Me<br />
chair/chair/chair<br />
Me<br />
Br<br />
Me H<br />
Me<br />
H H<br />
Cl<br />
Me<br />
Me<br />
Br<br />
OH<br />
Cl<br />
PhSeCl<br />
68%<br />
Cl<br />
Br<br />
O<br />
Me<br />
Me<br />
Cl<br />
Cl<br />
Me<br />
Cl<br />
H<br />
O<br />
Me<br />
H H<br />
Me<br />
17%<br />
Me<br />
H<br />
O<br />
Me<br />
chair/boat/chair<br />
Me<br />
Me<br />
Me<br />
Cl<br />
Cl PHICl<br />
Br<br />
Br<br />
2<br />
+<br />
23%<br />
19% Cl 33% Cl<br />
Cl<br />
Cl<br />
Williard, P. G., et al, J. Org. Chem., 1985, 50, 3738-3749.<br />
Cl<br />
Me<br />
O<br />
OAc<br />
Me<br />
O
Me<br />
O<br />
Me<br />
Cl<br />
Cl<br />
O<br />
Me<br />
Si<br />
Si<br />
O<br />
Me<br />
O<br />
O<br />
Synthesis of Plocamium <strong>Natural</strong> <strong>Products</strong>:<br />
Shea's T2IM Diels-Alder Approach<br />
Me<br />
Si<br />
Me<br />
Me<br />
Br<br />
PhICl 2<br />
61%<br />
OH<br />
OH<br />
3 steps<br />
66%<br />
O<br />
O<br />
Me<br />
Br<br />
O<br />
CO 2t-Bu<br />
shaw 55/56 2/4/02 2:45 PM<br />
O<br />
Cl<br />
O<br />
Cl<br />
Cl<br />
Tol/∆<br />
74%<br />
96%<br />
DIBAL-H<br />
85%<br />
Me<br />
Si<br />
Me<br />
Cl<br />
Me<br />
Me<br />
Si<br />
O<br />
OH<br />
Cl<br />
O Br<br />
Me<br />
Me<br />
one<br />
pot!<br />
Br<br />
OH<br />
MeMgBr/Mg°<br />
Cl<br />
O<br />
Me<br />
Br<br />
1) TPAP/NMO<br />
2) CrCl2/CHCl3 E/Z=94:6<br />
89%; 58%<br />
Me<br />
Si<br />
Me<br />
Me<br />
Si<br />
Me<br />
Cl<br />
O<br />
Mg<br />
MgBr<br />
NiCl 2(dppp)/ Cl<br />
OMgBr<br />
Synthesis of Callipeltoside Sidechain:<br />
Chloroalkene Cyclopropanation<br />
57%<br />
Cl<br />
Cl<br />
O<br />
diastereoselection >98:2<br />
Et2Zn, TFA,<br />
CH2I2 82%<br />
O<br />
CO 2t-Bu<br />
DIBAL-H<br />
90%<br />
Cl<br />
Cl<br />
R<br />
Me<br />
Shea, K. J., et al, J. Org. Chem., 1997, 62, 8962-8963<br />
Cl<br />
61%<br />
R=CH 2OH<br />
OH<br />
Br<br />
Olivo, H., et al, Org. Lett., 2001, 2, 4055-4058<br />
Evans, D. A., et al, Org. Lett., 2001, 3, 503-505<br />
Patterson, I., et al, Angew. Chem. Int. Ed., 2001, 603-607<br />
Cl<br />
NOVOZYM-435<br />
vinylpropionate<br />
I<br />
MeO 2C<br />
MeO 2C<br />
Synthesis of Virantmycin:<br />
Corey's Ortho-Azaxylylene Intramolecular Diels-Alder<br />
O LiCl<br />
+<br />
Me<br />
Pd(OAc) 2 (2 mol%)<br />
HOAc<br />
85%<br />
Me<br />
CO2Et O<br />
O<br />
N<br />
O<br />
Me Me<br />
Cl<br />
Me<br />
4 steps<br />
HO<br />
HO<br />
Cl<br />
Halomon: The Final Frontier<br />
• The biggest challenge in HNP synthesis is the preparation of acyclic halogenated terpenes<br />
• Only two syntheses of Halomon have been reported, and there is still much room for improvement<br />
OH<br />
Cl Me<br />
Br<br />
N +<br />
Me Me<br />
Cl -<br />
Cl Cl<br />
Viehe's Salt<br />
Br<br />
Halomon<br />
75%<br />
Me<br />
Cl<br />
1) TBSCl<br />
2) Et 4N + Cl 2 -<br />
59%<br />
Cl<br />
TBSO<br />
Cl<br />
Me<br />
Br<br />
Cl Me<br />
Br<br />
Bu 4NBrCl 2<br />
HPLC<br />
25%<br />
OH<br />
Cl<br />
OH<br />
Et 4N + Br 3 -<br />
97%<br />
MeC(OMe) 3<br />
pTsOH/ 170 °C<br />
55%<br />
Cl<br />
Me<br />
Cl DBU<br />
Cl<br />
Me<br />
86%<br />
Br<br />
Cl<br />
Cl<br />
Br<br />
Neither Synthesis<br />
Gives ANY<br />
DIastereoselectivity<br />
Cl<br />
TBSO<br />
OH<br />
Me<br />
Br<br />
Br<br />
O<br />
Cl<br />
OMe<br />
MgBr<br />
87%<br />
Me<br />
Cl<br />
Me<br />
Me<br />
6 steps<br />
73%<br />
Cl<br />
Br<br />
Bu4NBrCl2 HPLC<br />
27%<br />
Cl<br />
Myrcene<br />
CHO<br />
Mioskowski, C., et al, Angew. Chem. Int. Ed., 1998, 37, 2085-2086<br />
Hirama, M., et al, Angew. Chem. Int. Ed., 2000, 39, 3430-3431<br />
Outlyers<br />
• Several recent diastereoselective syntheses of halogenated natural products<br />
employ selective, but not terribly general, halogenation reactions.<br />
Me<br />
Me<br />
Me<br />
Me<br />
O<br />
O<br />
O 75% Me<br />
Me H<br />
(-)-Carvone<br />
O -<br />
HO 2C<br />
OTBS<br />
NHCBz<br />
PhtN NPht<br />
O<br />
O<br />
O<br />
HS<br />
LiCl/<br />
CSA<br />
N +<br />
EDC<br />
Fukuyama, T., et al, J. Am. Chem. Soc., 1994, 116, 3125-3126<br />
Carreira, E. M., et al, J. Am. Chem. Soc., 2000, 122, 8793-8794<br />
shaw 59/60 2/4/02 2:49 PM<br />
N<br />
H<br />
+ CO2 S<br />
Cl<br />
Me<br />
OTBS<br />
H<br />
O<br />
NHCBz<br />
PhtN NPht<br />
HN<br />
RO<br />
Cl<br />
NH<br />
O<br />
O<br />
N<br />
NHR NHR<br />
O<br />
H HO<br />
H<br />
N<br />
N<br />
H<br />
CCl 4<br />
NH<br />
Me<br />
Me<br />
H<br />
Cl Me<br />
H<br />
NH<br />
Me<br />
NC<br />
(-)-Hapalindole G<br />
Cl<br />
Axinellamines<br />
OTBS<br />
NHCBz<br />
O<br />
O<br />
Me<br />
PhtN NPht<br />
diastereoselection >91:9
H 2N<br />
N<br />
H 2N<br />
H<br />
N<br />
H<br />
N<br />
N<br />
NH 2<br />
R 1<br />
N<br />
N<br />
O<br />
OH<br />
diastereoselection 81:19<br />
R 2<br />
H 2N<br />
N<br />
Outlyers II<br />
H 2N<br />
H<br />
N<br />
H<br />
N<br />
N<br />
H<br />
Cl +<br />
H<br />
NH 2<br />
Bn OTIPS<br />
OTIPS<br />
O<br />
Bn<br />
N<br />
N<br />
NTs<br />
O<br />
Bn<br />
O<br />
N<br />
N<br />
O<br />
H<br />
NTs<br />
O<br />
H<br />
OH<br />
Bn Cl<br />
OTBS<br />
∆; 79%<br />
NCS; 79%<br />
Bn OTIPS<br />
Bn OTIPS<br />
O<br />
N<br />
N H<br />
NTs<br />
mCPBA<br />
O<br />
N<br />
N OH H<br />
NTs<br />
Bn<br />
Bn<br />
H O<br />
H O<br />
shaw 61/62 2/4/02 2:51 PM<br />
OTBS<br />
R 1<br />
N<br />
N<br />
Summary<br />
O<br />
R 2<br />
H 2N<br />
HN<br />
HN<br />
N<br />
Cl<br />
HN<br />
H2N HO<br />
RO<br />
Cl<br />
N<br />
N<br />
HN<br />
H<br />
N<br />
H<br />
N<br />
H<br />
NH 2<br />
NH<br />
NH<br />
H<br />
R 1<br />
X<br />
Palauamines/<br />
Styloguanidines<br />
OH<br />
NHR<br />
Axinellamines<br />
NHR<br />
Kinnel, R. G., et al, J. Am. Chem. Soc., 1993, 115, 3376-3377<br />
Romo, D., et al, Org. Lett., 2001, 3, 1535-1538<br />
Poitier, P., et al, Eur. J. Org. Chem., 2001, 237-243<br />
• Many selective approaches to the construction of halogen-bearing stereocenters<br />
have been developed<br />
• Nucleophilic displacement of alcohols is an important and selective method for<br />
the construction of a bromine-bearing center<br />
• Mono- and polycyclizations provide the opportunity to use the introduction of bromine<br />
to control the stereo- and regiochemistry of other stereogenic centers<br />
• Few methods are truly general and most are developed in the context of one particular<br />
natural product class<br />
Y<br />
O<br />
R 2